BackEssa Pharma Overview

Essa Pharma Intangible Assets

Essa Pharma's intangible assets is $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

Essa Pharma Intangible Assets History

Loading

Essa Pharma vs. peers: Intangible Assets Comparison

Loading

Essa Pharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Essa Pharma (EPIX) FAQ

Essa Pharma (EPIX) currently reports a intangible assets of $0 as of June 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Essa Pharma's intangible assets history and peer comparisons.

Essa Pharma's intangible assets changed from $0 to $0 (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Essa Pharma reported $0 in intangible assets as of June 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Essa Pharma, and consider following EPIX for alerts when major investors trade the stock.

Essa Pharma is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EPIX with unrelated industries.